Forensic Analysis · Technology / Software · as of Sep 25, 2026
Widepoint Corp (WYY)
A forensic read on Widepoint Corp built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Distress
Financial health
-3.6
Distress distance
Clean
Earnings quality
4
Forensic signals
-23.9%
ROE
5.6%
Revenue growth
The financial-health reading above compares this company's equity at BOOK value, not at what the market currently pays for it — this free snapshot doesn't pull live market data. Treat it as a rough read, not the final word.
This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (red flags, auditor quality, say on pay, board independence, going concern, valuation). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.
Widepoint Corp earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads -3.6, placing it in the Distress zone (based on book value, not market value, since this free snapshot doesn't pull live market data — treat this zone as a rough read, not the final word). 4 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
-36.2%
FY2025
Return on invested capital.Return on invested capital is -36.2% in the latest fiscal year, against -22.6% in FY2023, having run between -36.2% and -12.5% across FY2023–FY2025 with no direction held. After-tax operating profit was ($3M) in FY2023 and ($2M) in FY2025, with operating income at -3.5% of revenue in FY2023, -1.3% in FY2024 and -1.8% in FY2025. The capital base behind it came down -53% across FY2023–FY2025, from $13M to $6M, so this is a return struck on a smaller base rather than a record of money put to work.
+4.6%/yr
FY2023–FY2025
Share-count dilution.Diluted share count changed +10% over the last 2 years to FY2025 (+4.6%/yr). The count is growing: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~4.6% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2023 has been diluted ~9%.
36d DSO
FY2024→FY2025
Receivables vs revenue.Days sales outstanding moved from 31 to 36 days FY2024→FY2025 (receivables +26% vs revenue +6%). Across FY2023–FY2025 the day count ran 28 → 31 → 36 days — the latest step continues a climb that was already under way, which is the persistence that separates a collection problem from a busy quarter. Receivables grew, but deferred revenue grew +28% over the same period too — rising alongside rising unearned revenue reads as upfront billing on multi-period contracts, not slipping collections. Both figures are measured on period-end balances rather than the beginning-plus-ending average, because averaging needs the balance a year before every reading — FY2024's opening balance is on file, but across the 3 fiscal years read here (FY2023–FY2025) the average yields only 2 day counts (1 step), too few to tell a climb from one year's move.
0.5% of rev
Key fundamentals
Latest Revenue$150.5M
Revenue Growth YoY+5.6%
Revenue CAGR (2yr)+19.1%
Net Margin-1.8%
Free Cash Flow$5.4M
Return on Equity-23.9%
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Widepoint Corp's actual 10-K/10-Q/8-K filings?
Stock-based comp load.Stock-based compensation ran 0.5% of revenue and 14% of free cash flow in FY2025 — about $0.08 per diluted share. No cash left the business to pay it, which is why operating cash flow adds it back. Net of repurchases the diluted count still rose about 4.6% a year, and the rate is falling. Stock compensation is one source of that issuance; acquisition consideration, equity raises, convertibles and other employee plans also net into the count, and these figures do not separate them.